Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
1.189
-0.011 (-0.90%)
Nov 21, 2024, 12:24 PM EST - Market open
Spero Therapeutics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Spero Therapeutics stock has a target of 5.00, which predicts an increase of 320.45% from the current stock price of 1.19.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for SPRO stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 2 | 2 | 2 | 1 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 3 | 3 | 3 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
TD Cowen | TD Cowen | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 18, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Nov 15, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7 → $5 | Strong Buy | Maintains | $7 → $5 | +320.45% | Nov 4, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +488.63% | Oct 3, 2024 |
TD Cowen | TD Cowen | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Aug 6, 2024 |
Financial Forecast
Revenue This Year
30.66M
from 103.78M
Decreased by -70.46%
Revenue Next Year
18.02M
from 30.66M
Decreased by -41.22%
EPS This Year
-1.15
from 0.43
EPS Next Year
-1.14
from -1.15
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 54.0M | 55.7M | 27.6M | ||
Avg | 30.7M | 18.0M | 19.1M | ||
Low | 18.8M | n/a | 11.0M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -47.9% | 81.5% | 53.2% | ||
Avg | -70.5% | -41.2% | 6.1% | ||
Low | -81.9% | - | -39.1% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -0.38 | -0.13 | -1.40 | ||
Avg | -1.15 | -1.14 | -1.43 | ||
Low | -1.67 | -1.98 | -1.44 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.